Israel's Health Ministry sets out guidance on the brain-infecting ameba

Israel's Ministry of Health has published a public information page on Naegleria fowleri, a single-celled organism found in fresh water that can, in rare circumstances, cause a rapidly progressing brain infection. The advisory, issued through the ministry's Epidemiology Division, describes where the ameba lives, how infection occurs, the symptoms it produces and the steps swimmers can take to reduce their exposure.

The ministry states plainly that infections of this kind are extremely rare, and that the resulting illness, known medically as primary amebic meningoencephalitis, progresses quickly once symptoms appear. The page is filed under the ministry's topics for diseases, environmental health and bathing sites, and it directs readers to a separate collection of press releases on the subject.

What the Epidemiology Division is

The Epidemiology Division sits within Israel's Ministry of Health and is the unit responsible for tracking communicable disease and issuing public guidance on it. Israel has no equivalent of a separate national public health agency operating outside the ministry, so advisories of this type, on everything from seasonal illness to water safety, are published directly by ministry units on the government's gov.il portal, in Hebrew and in English. The page carries an original publication date and a later update date, indicating it is maintained as standing reference material rather than issued in response to a single incident.

How the ameba causes infection

According to the ministry, Naegleria fowleri is present in all bodies of fresh water, including rivers and hot springs, and thrives in water reaching temperatures as high as 45 degrees Celsius. It can also, very rarely, be found in poorly maintained swimming pools. The conditions the ministry associates with risk are those of high summer: hot weather, warmer water and lower water levels.

The advisory explains that infection requires contaminated water to enter through the nose, after which the ameba passes through the nasal mucus, reaches the olfactory nerve and travels to the brain, where it destroys brain tissue and nerve cells. That damage, the ministry says, is permanent. This is the origin of the informal name the page cites, the "brain eating ameba."

The ministry is equally specific about the ways infection does not happen. Swallowing water containing the ameba does not cause infection. Nor does swimming in salt water, a point of some relevance in a country whose most heavily used bathing areas are along the Mediterranean coast. The infection also cannot be passed from one person to another.

Symptoms and the speed of the illness

The early signs listed by the ministry are headache, fever, nausea and vomiting. As the infection advances, it can produce a stiff neck, confusion, loss of balance, seizures and coma. Once symptoms begin, the ministry states, the infection progresses rapidly and most people who contract it die within 1 to 18 days.

Diagnosis is made by laboratory testing, and the ministry says those tests are available at its National Center for Public Health Laboratories. On treatment, the page is candid about the limits of current medicine: a combination of antibiotics and antifungal drugs is being tried, but the ministry says these do not work well, and it stresses the importance of beginning treatment early.

The precautions the ministry recommends

The guidance is built around keeping water out of the nose. The ministry recommends plugging the nose when swimming or diving in natural fresh water and using safety equipment such as nose clips. It advises against digging in the sand in shallow water at natural freshwater sites, where it says amebas are more likely to be found, and it recommends keeping the head above water in hot springs. For nasal rinsing at home, the ministry says to use distilled water or solutions bought at a pharmacy rather than tap water.

What the advisory does not say

The page does not report any case in Israel, does not state how many infections have been recorded in the country, and does not name any location where the ameba has been detected. For frequency it cites only a figure for the United States, which the ministry describes as fewer than 10 cases a year. It gives no seasonal alert, no closure of any bathing site, and no indication of whether the guidance was updated in response to a specific event. Because this account rests on a single ministry publication, none of these points can be filled in from elsewhere here.